Back to top
more

IDEXX Laboratories (IDXX)

(Delayed Data from NSDQ)

$423.65 USD

423.65
553,842

-6.17 (-1.44%)

Updated Nov 14, 2024 04:00 PM ET

After-Market: $423.84 +0.19 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (69 out of 250)

Industry: Medical - Instruments

Zacks News

Why IDEXX Laboratories (IDXX) Could Be an Impressive Growth Stock

If you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDEXX Laboratories (IDXX).

    IDEXX Laboratories (IDXX) Beats Q1 Earnings, Raises View

    IDEXX Laboratories Inc. (IDXX) recorded first-quarter 2017 earnings per share (EPS) of 77 cents, up 51% (up 53% at constant exchange rate or CER) year over year on a reported basis.

      IDEXX Laboratories (IDXX) Beats on Q1 Earnings & Revenues

      IDEXX's first-quarter earnings per share came in at 77 cents, an increase of 51% year-over-year on reported basis. On a constant currency basis, this figure improved 53% year over year.

        Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?

        Investors may buy IDEXX Laboratories (IDXX) Ahead of Earnings depending on its decent Zacks Rank and earnings ESP in the positive territory.

          IDEXX Laboratories (IDXX) Q1 Earnings: Surprise in Store?

          IDEXX Laboratories, Inc. (IDXX) is slated to report first-quarter 2017 results on Apr 28, before the opening bell.

            Becton (BDX) Gets FDA 510(k) for New Flow Cytometer System

            Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

              Fresenius (FMS) Acquires 70% Stake in Kunming Wuhua Hospital

              Fresenius Medical Care AG & Co. KGAA announced the acquisition of 70% equity interest in Kunming Wuhua Health Hospital in China.

                Mazor Expects Higher Q1 Revenue, Receives Mazor X Orders

                Mazor Robotics Ltd. (MZOR), recently announced that it expects to report record first-quarter 2017 revenue of approximately $11.5 million compared with only $6.4 million in the year-ago quarter.

                  IDEXX Laboratories' CAG Revenues Solid, Competition Rife

                  On Apr 5, we issued an updated research report on Delaware NJ-based IDEXX Laboratories, Inc. (IDXX).

                    Teleflex (TFX) Acquires Medical Device Provider Pyng Medical

                    Teleflex Inc. (TFX), a global provider of medical technologies, announced that it has acquired Pyng Medical Corporation.

                      Becton, Dickinson Takes Over Caesarea Medical Electronics

                      Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has acquired Caesarea Medical Electronics.

                        5 Stocks that Outperformed the S&P 500 in Q1

                        First quarter was quite impressive and we have selected five top-ranked stocks that surpassed the S&P 500 index during the period.

                          Varian (VAR) Eclipse Software Tops in International Studies

                          Varian Medical Systems, Inc. (VAR) recently announced that its Eclipse treatment planning software has topped in two competitive international plan studies.

                            PAREXEL (PRXL) Launches Sensor for Clinical Trial Market

                            PAREXEL International Corporation (PRXL), a global biopharmaceutical services company and provider of clinical research and logistics, recently announced the launch of its patient sensor solution.

                              AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View

                              AngioDynamics Inc. (ANGO), a leading provider of minimally invasive medical devices, reported adjusted earnings of 19 cents per share in the third quarter of fiscal 2017.

                                David Bartosiak headshot

                                New Zacks Rank Strong Buy Stocks Breaking to Highs

                                Today???s Daily Dive included a brief overview of the stellar action on crude oil, including intermediate term targets for the contract.

                                  Envision (EVHC) Teams Up with Lyft to Focus on Transportation

                                  Envision Healthcare Corporation (EVHC) recently announced that it has teamed up with on-demand transportation service provider Lyft.

                                    Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife

                                    On Mar 29, we issued an updated research report on North Kansas City, MO-based Cerner Corporation (CERN) ??? a leading global provider of healthcare information technology solutions (HCIT).

                                      Here's Why You Should Steer Clear of Mednax (MD) for Now

                                      Over the past 6 six months, shares of Mednax (MD) have gained 4.9%., underperforming the 9.8% increase logged by the Zacks categorized Medical - Hospital industry.

                                        Intuitive Surgical Hits 52-Week High on Multiple Positives

                                        Shares of leading provider of robotic-assisted surgery, Intuitive Surgical, Inc. (ISRG) rallied to a new 52-week high of $770.28 on Mar 28, closing a tad lower at $764.47.

                                          3 Medical Device Stocks to Brave Policy Uncertainty

                                          We believe stocks with strong fundamentals that also have a significant share of their business overseas may well brace themselves in the on-going conundrum. They will make lucrative additions to your portfolio.

                                            IDEXX (IDXX) Poised on Strong Fundamentals, Innovations

                                            On Mar 14, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).

                                              ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI

                                              A new study demonstrates that ABIOMED's flagship Impella 2.5 heart pump can reduce the risk of acute kidney injury during high-risk percutaneous coronary intervention (PCI).

                                                Cooper Companies (COO) Receives ISO 15189 Accreditation

                                                The Cooper Companies Inc. (COO) announced that its London and Nottingham-based laboratories received the International Organization for Standardization 15189 accreditation.

                                                  C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain

                                                  We issued an updated research report on C. R. Bard Inc. (BCR) on Mar 8, 2017.